688253.SHG Innovita Biological Technology Co. Ltd. A

Healthcare Biotechnology Shanghai Stock Exchange
48.70 CNY
Close of Nov 4, 2026
29.78 73.58
Market cap
CNY 6.72B
P/E
116.0x
P/B
3.16x
ROE
3.1%
Dividend yield
1.12%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 688253.SHG undervalued?

Graham number

The Graham number of Innovita Biological Technology Co. Ltd. A cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Innovita Biological Technology Co. Ltd. A fundamental analysis

No fundamental analysis for Innovita Biological Technology Co. Ltd. A yet.

Innovita Biological Technology Co. Ltd. A stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Innovita Biological Technology Co. Ltd. A

Innovita Biological Technology Co., Ltd., a biopharmaceutical enterprise, engages in research and development, production and sales of POCT rapid diagnostic products. It offers Covid-19 test, respiratory disease test, gastrointestinal disease test, fertility test and TORCH test, neurological testing and hepatitis test, as well as tropical disease test such as neurological testing. The company was founded in 2006 and is based in Beijing, China.

Full company profile